Sagefield Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Sagefield Capital’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,600	Closed	-$539K	–	128
2023 Q2	$539K	Buy	+11,600	New	+$401K	0.12%	79

Sagefield Capital's DICE Position: Q3 2023 in Review

Sagefield Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 11,600 shares — an estimated $539K sold.

Sagefield Capital first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $539K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Sagefield Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Sagefield Capital sold 11,600 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $539K.
Sagefield Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Sagefield Capital's DICE Therapeutics, Inc. Common Stock position peaked at $539K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Sagefield Capital's 13F filing for Q3 2023, filed 14 Nov 2023.